Skip to main content

Table 2 Total PR mRNA expression before and after treatment as a function of PR status on day 1

From: Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

  

Median ± SD of PR expression (2^-∆Ct)

PR status at day 1

Day 1

Day 15

Control group

PR+

0.05 ± 0.02

0.04 ± 0.06

PR-

0.02 ± 0.00

0.03 ± 0.00

Treated group

PR+

0.09 ± 0.07

0.03 ± 0.03*

PR-

0.02 ± 0.01

0.03 ± 0.05

  1. PR: Progesterone receptor; SD: Standard deviation; PR+: Progesterone receptor positive; PR-: Progesterone receptor negative. *P < 0.05.